False-positive selections and contaminants were excluded through iterative rounds of heterogeneous classification using three references and four decoy classes generated from noise particles through ab initio reconstruction in cryoSPARC (v4.5.0), resulting in stacks of 877,231, 815,775, and 906,048 particles from each dataset
44 46 , 50 Figure 2Evidence Network for Change in A1C and Weight at 24 Weeks for NMA of Semaglutide Versus Other GLP-1 Agonists FIGURE CONTAINED CONFIDENTIAL INFORMATION AND WAS REDACTED AT THE REQUEST OF THE MANUFACTURER Figure 3Evidence Network for Change in A1C and Weight at 52 Weeks for NMA of Semaglutide Versus Other GLP-1 Agonists FIGURE CONTAINED CONFIDENTIAL INFORMATION AND WAS REDACTED AT THE REQUEST OF THE MANUFACTURER Table 59NMA Results for Change From Baseline in A1C for GLP-1 Agonists Table 60NMA Results for Change from Baseline in Weight (kg) for GLP-1 Agonists Results of Indirect Treatment Comparison for Semaglutide Versus SGLT2 Inhibitors as Add-On to Metformin Objective The objective of this indirect treatment comparison (ITC) was to assess the relative efficacy and safety of once-weekly semaglutide compared with sodium-glucose cotransporter-2 (SGLT2) inhibitors for the treatment of adults with type 2 diabetes who were inadequately controlled with metformin
From diagnosis through diet, supplements, and the four subtype framework
When to Investigate Further: Identifying Underlying Causes and Supportive Measures When diarrhea is severe, consider checking for bile acid malabsorption or pancreatic insufficiency if stools are fatty or greasy
A provider is unlikely to take a patient off semaglutide as long as they are seeing results and not experiencing any severe side effects
